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 Many cancers are known to have genetic rearrangements, as these rearrangements 
develop abnormalities that can lead to certain types of cancer. Many of these genetic 
rearrangements can be caused by transposons, which are DNA sequences that can change 
its position and move to other positions within the genome. Transposons move to and 
integrate into a new location by the action of transposase enzymes, and recently genes 
that code for proteins similar to transposases and with transposase activity have been 
identified in the human and other vertebrate genomes.  In this study, one of these genes, 
human piggyBac transposable element derived 5 (PGBD5), was examined for its possible 
role in the development of neurons in the brains of mice because this gene has been 
shown to be expressed in neurons of the cerebral cortex. This project tested whether 
introduction of the PGBD5 transposon through a pCAG overexpression vector altered the 
development of neural cells. PGBD5 was introduced during the development of the brain 
in mice, and we examined the effects on neuron number, size, and position. The 
technique to introduce the transgene was In Utero Electroporation (IUE) and fluorescent 
microscopic imaging, and quantification was used to assay its effects relative to a control 
that only received a fluorescent marker.  We quantified and compared cell size, location, 
and cell counts of PBGD5 overexpressing and control cells and found that while there 
were no significant differences in cell counts, there were significant differences in cell 
size and cell position. The experimental cells showed an increase in cell size and a 
decrease in cell distance from the cortex when compared to the control cells. Our results 
indicate that PGDB5 may play a role in the development of neural cells. 
 
Introduction:  
 Up until the late 20th century, genes were seen as stable arrangements that did not 
move within the genome of somatic cells. However, the second half of the 20th century 
saw major advancements in the field of DNA transposons and the idea that genes are 
mobile elements emerged from the work of Barbara McClintock.  Dr. McClintock was 
investigating maize at Cold Spring Harbor Laboratory. She noticed that as her maize 
plants began to grow, some maize leaves had different color patterns, and she 
hypothesized that perhaps some maize leaf cells had lost or gained genetic information 
that could attribute to these genetic mutations that she noticed. However, when 
examining on a chromosomal level, Dr. McClintock discovered that in fact some of the 
genetic material on these chromosomes switched positions with another segment on a 
different chromosome. She also discovered that the switching of genes could be 
controlled via environmental factors, and that such genetic “jumping” mutations could 
also be reversed (McGrayne, 1998). Initially, her discovery of transposons was ignored, 
and it was not until 30 years later, when transposons were later found to exist in bacteria, 
that Dr. McClintock was awarded a Nobel Prize for her work (Ravindran, 2012).  
 Along with the fact that transposons can cause rearrangement, there are also other 
known ways to edit/alter the genome. The most well known engineered nuclease is the 
clustered regularly interspaced short palindromic repeats (CRISPR) system. CRISPR has 
various subtypes that involve different enzymes, and the most common enzyme that is 
used in CRISPR technology is CRISPR-Cas9. This technique involves the basic idea of 
using Cas9, a RNA-guided endonuclease enzyme that can cleave DNA, and a modified 
RNA sequence. The RNA sequence can bind to a specific part of DNA that is of interest, 
and the Cas9 can recognize where the RNA is bound and can cleave the selected DNA 
region (Jinek et al., 2012). An alternative to CRISPR-Cas9 is CRISPR-Cpf1. CRISPR-
Cpf1 is very similar to CRISPR-Cas9, as it involves very similar concepts. Cpf1 is 
another type of RNA-guided endonuclease enzyme. However, Cpf1 is a smaller enzyme 
than Cas9, which allows for even more specificity and gives the ability for “staggered” 
cuts. This allows for the ability to create sticky ends, which is beneficial for the 
researcher if he/she wants to introduce any new genes into the genome (Ledford, 2015). 
 Zinc finger nucleases (ZFNs) are another class of engineered nucleases. ZFNs 
utilize the concept of zinc finger domains, which is a domain that contains a high number 
of zinc ions. ZFNs fuse the zinc finger domains with DNA cleavage domains, and this 
can be useful in genome editing if the zinc finger domains are engineered to specifically 
target a gene of interest that will fuse with the zinc finger domain and the DNA cleavage 
domain (Baker, 2012). 
 Transcription activator-like effector nucleases (TALENs) are a type of restriction 
enzyme, and are another family of engineered nucleases. TALENs utilize a similar 
concept with ZFNs. Instead of using zinc finger domains, TALENs use TAL effectors, 
which are proteins secreted by the Xanthamonas bacteria, to bind to specific DNA 
binding regions and thus fuse with the DNA cleavage regions to allow for genome editing 
(Boch, 2011). 
 This thesis project mainly focused on transposon systems to alter/arrange genomic 
DNA. Transposons are defined as a chromosomal segment of DNA that can rearrange 
genetic material (Pray, 2008). The significance behind this is that it allows researchers to 
manipulate the genome and edit/delete out certain regions to see how the manipulations 
can affect certain tissues. There are many different classes of transposons. One common 
way to divide transposons is to have two classes, one that utilizes reverse transcription 
(i.e. RNA getting transcribed into DNA) and one that does not utilize reverse 
transcription. The class that does not utilize reverse transcription is called Class II 
transposons (Pray, 2008). This class encodes for the enzyme transposase, which allows 
these transposons to have a cut-and-paste mechanism when rearranging along the 
genome. These Class II transposons have terminal inverted repeats that is recognized by 
the transposase to allow for the cut and paste method to occur. Class I transposons do 
something differently to function properly, and it does not requires the use of 
transposases. Instead of transposases, Class I transposons make RNA intermediates so 
that reverse transcription enzymes can reverse transcribe the RNA back to DNA. By 
transcribing the RNA back to DNA, the transposon can now insert itself across the entire 
genome (Pray, 2008).   
 Within Class I transposons contains two types of categories. One type of Class I 
transposon has long terminal repeats (LTRs) at the ends of the transposon, while the other 
type of transposon does not contain any LTRs (Pray, 2008). Today, it is known that in 
humans, it is the non-LTR Class I transposons that are active and capable of “jumping” 
around the human genome and inserting itself. Transposons can also be categorized as 
either autonomous or non-autonomous transposons. Autonomous transposons are known 
to move on their own and do not require any other sort of element, while non-
autonomous transposons require other transposons nearby to move. Non-autonomous 
transposons do not have protein elements such as transposases or reverse transcriptases, 
so in order to move around they need to use the transposases/reverse transcriptases of 
other autonomous transposons.  
 The fascination of transposons, specifically transposons that use transposase to 
function, has been of particular importance lately. This particular project wanted to 
investigate a specific DNA transposase called piggyBac transposable element derived 5 
(PGBD5) that works with the piggyBac type 2 transposon. There are currently two 
distinct classes of known transposon systems that work well for the use in mammal cells, 
those two classes being Sleeping Beauty (SB) and piggyBac (PB) (LoTurco et al., 2012). 
Both utilize transposases to function correctly. The SB transposon system works by 
moderating the “cut-and-paste” mechanism at TA-dinucleotide sequences (Huang et al., 
2010). However, the main downside to using SB transposons is that it is not the most 
efficient transposon model, as it has a lower transposition rate compared to the second 
transposon system, piggyBac (Huang et al., 2010).  
 The PB transposon system has some slight differences to the SB transposon 
system. One of these differences is that the PB system targets and mediates TTAA-
tetranucleotide sequences in mammalian cells (Huang et al., 2010). The PB transposon 
system will recognize and cut out transposon-specific inverted terminal repeat sequences 
(ITRs) that are found on the ends of the gene of interest along with the gene of interest. 
Then, the PB transposon will paste this sequence in between the TTAA tetranucleotide 
sequences and integrate the gene of interest into that specific chromosomal site. This PB 
transposon system was found to have one the most consistent and highest transposition 
efficiencies among the known transposon systems that can be used in mammal cells 
(Huang et al., 2010), which explains why it is the most preferred transposon system 












Figure 1. The piggybac transposon system. The PB system recognizes ITRs and cuts 
between the two ITRs, allowing for the cut and paste of the ITRs along with the gene of 
interest. The gene of interest is then pasted in between two TTAA regions on the 
chromosome.  
  
 Previous work has been done on PGBD5 looking into its effects on human 
rhabdoid tumors. Researchers from Henssen et al. found that the rearrangements in the 
genome of these tumors had PGBD5-specific signal  (PSS) sequences that can cause 
rearrangements in DNA found in rhabdoid tumor cells, which lead to the finding of 
inactivation of tumor-suppressor genes (Henssen et al., 2017). These transformed cells 
were done through the catalytic residues found in the PGBD5 transposase domain as well 
as changes in the DNA caused from end-joining DNA repair and induced structural 
rearrangements within PSS breakpoints (Henssen et al., 2017). 
 Researchers and databases have discovered some basic information regarding 
PGBD5, such as where it is localized in the brain, what proteins it’s associated with, and 
what cell types PGBD5 is found in. It has been discovered that PGBD5 is mostly found 
in brain and central nervous system (CNS) cell types. The BioGPS gene pool database 
examined 79 different types of cell tissue, and found that PGBD5 gene expression was 




















 Figure 2. PGBD5 gene expression in mouse tissue. Data has found that PGBD5 is 
primarily localized in brain and CNS tissue and very little localization is found in other 
cell types such as the spinal cord or organ tissue. 
 
 PGBD5 localization in the specific areas of the mouse brain was examined via 
online databases such as Allen Brain Atlas and GenePaint. Previous research has found 
that PGBD5 is primarily localized in certain areas of the adult mouse brain and 
embryonic mouse brain, and some of these areas do not necessarily match. Coronal and 
sagittal slices from Allen Brain Atlas show that PGBD5 in mature mice brains are found 
primarily in regions of the olfactory bulb, hippocampus, and cerebellum. 
 Figure 3. Coronal and sagittal slices of adult mouse brain. Sections A-C are coronal 
slices of an adult mouse brain showcasing the localization of PGBD5. Section A shows 
high levels of expression in the cerebellum, Section B shows expression in the 
hippocampus, and section C shows expression in the olfactory areas. Section D is a 
sagittal slice of an adult mouse brain. The 3 arrows point to the olfactory areas, 
hippocampus, and cerebellum in respective order from left to right. 
 
 As stated earlier, the PGBD5 expression found in embryonic mice brains differed 
slightly from the adult mice brains. GenePaint databases show sagittal brain slices of 
embryonic mice brain tissue. These images show that while PGBD5 was found in brain 
areas such as the medial pallium and prepontine isthmus (Pavelitz et al., 2013), which are 
embryonic brain areas that give rise to the development of the hippocampus and 
cerebellum, respectively, PGBD5 expression was also found in areas in the embryonic 
brain that give rise to the hypothalamus and medulla.  




















Figure 4. Sagittal slices of embryonic mice brain tissue.  Sections A-C are sagittal 
slices of embryonic mice brain tissue that show the localization of PGBD5. Section A 
shows PBGD5 expression in the medial pallium region, which is known to give rise to 
the development of the hippocampus. Section B shows high PGBD5 expression in the 
prepontine isthmus brain region, which is known to give rise to the development of the 
cerebellum. Section C shows expression in the hypothalamus and medulla in respective 
order from left to right. . These are the only two regions that do not show expression of 
PGBD5 in adult brain tissue. 
 
 PGBD5 is also known to be associated with other various proteins. Databases 
such as GeneMania were utilized to examine what proteins were associated with PGBD5 
and how they were associated. It was discovered that PGBD5’s main physical interaction 




 Figure 5. Protein associations for PGBD5. Sections A-B show various protein 
associations for PGBD5. Section A shows the proteins that are co-localized along with 
PGBD5. Section B shows the entire map of associated proteins and their various different 
associations with PGBD5. The pink color lines show the physical interactions associated 
with PGBD5. The purple color lines show the co-expression interactions. The yellow 
color lines show which proteins share the same protein domains as PGBD5. 
 
 Some databases such as Linnarson Lab were able to show what specific cell lines 
are associated with PGBD5. As expected, the main cell lines that often are associated 
with PGBD5 are various types of neurons, specifically neurons located in the 
hippocampus. This was the case for cell lines such as CA1 and CA2 pyramidal neurons. 
CA1 and CA2 are subareas in the hippocampal structure (Andersen, 2007), and this 







regions of mice brains. Non-neuronal cell lines such as oligo and astro cell lines showed 


















Figure 6. Cell expression in a mouse brain and cell lines associated with PGBD5. 
Section A shows the cell expression found in a mouse brain. Expression was mostly seen 
in the cortex areas. Section B shows various cell liens were measured for the amount of 
PGBD5 expression found in the cells. Cell lines such as CA1 and CA2 were found to 




 Plasmids were constructed and prepped for this experiment. The piggybac 
transposon system utilizes two plasmids, helper plasmid and donor plasmid, so it is 
imperative to design the helper plasmid (PCAG-PBase), which provides the piggybac 
transposase, and the donor plasmid (pBCAG-eGFP), which provides the CAG-eGFP 
gene of interest. 
 The first step in preparing the plasmid was to design the forward and reverse 
sgRNA primers. This was done by adding the forward and reverse oligos as well as 
ddH2O, ligation buffer, and T4PNK. Then, this reaction mixture was phosphorylated and 
annealed in a PCR machine to prepare for insertion. This sgRNA oligo duplex mixture 
was then mixed with the pCAG-PBase backbone plasmid, buffer, ATP, EcoR1 and Not1 
restriction enzymes, ligase, and ddH2O. This was then placed in a PCR machine. 
 The next step was to prepare the miniprep culture. Once isolated bacterial 
colonies were grown for both the experimental and control, the cells were harvested by 
centrifuging the Lysogeny Broth (LB) culture. The supernatant was then removed, and 
the cell pellet was resuspended in P1 buffer. Next, P2 buffer was added and mixed to 
allow for the lysis of cells. After the solution turned blue, the P3 buffer was added and 
mixed, and the mixture turned colorless. This mixture was centrifuged for 10 min at max 
speed. Afterwards, the supernatant was added to a spin column, due to the fact that the 
plasmid DNA was now in the supernatant. The spin column was then centrifuged, and the 
flow through was discarded. The column was then washed with PB buffer and spun so 
that the flow through could be discarded. PE buffer was then added for another wash, and 
it was also spun and the flow through was discarded. Finally, the spin column was 
transferred to fit in a microcentrifuge (MCF) tube. The EB buffer was added to the spin 
column, and after waiting for 1 min, the spin column was centrifuged for 1 min at max 
speed. The flow through that was collected by the MCF tube contained the plasmid DNA. 
This miniprep was done so that Sanger sequencing could then be performed to verify the 
insertion of sgRNA. Once it was verified, a maxiprep was done to produce higher 
amounts of plasmid DNA. 
 The maxiprep procedure followed the same steps as the miniprep. It involved the 
same idea of first spinning down the pellet before adding a buffer to resuspend. Then a 
lysis buffer was added to release the DNA, followed by a neutralization buffer to stop the 
lysis. Then, after centrifugation, the supernatant was transferred to a spin column for 
further washing via buffers that were previously mentioned and further centrifugation, 
resulting in a DNA solution that is collected in the MCF tube. After collecting the 
plasmid DNA, a Nanodrop was used to analyze the quantity of DNA concentration. 
 After analyzing and quantifying the DNA concentration, the IUE mix was then 
prepared. DNA, PBS, and sterile green dye were added to each plasmid at their respective 
desired concentrations. For the control plasmid DNA mix, the pBCAG-eGFP plasmid 
required 6ug concentration, so 5ul solution was added to the mix, and the pBCAG-
mCherry plasmid required 5.5ug concentration, so 5.4ul solution was added to the mix. 
For the experimental plasmid DNA mix, the pCAG-PBGD5 plasmid required 5.5ng 
concentration, so 5.4ul solution was added to the mix, and the pBCAG-eGFP plasmid 
required 5.5ng concentration, so 5.4ul solution was added to the mix. 
Figure 7. Plasmid maps of the donor and helper plasmids. Section A shows the 
plasmid map of the donor pBCAG-eGFP plasmid. This plasmid contains the CAG-eGFP 
transgene that is of interest. Section B shows the plasmid map of the helper pCAG-PBase 
plasmid. This plasmid contains the piggybac transposase that is necessary to catalyze the 
movement of the transposon.	 
 
IUE 
 In order to successfully modify genes in the embryonic brain, an in utero 
electroporation (IUE) operation will be done on pregnant mice. The definition of an IUE 
is to inject plasmids that carry the gene of interest as well as any other vectors into the 
mouse brain. Then, electroporation will allow the plasmids to be drawn into the cells. 
This operation allows one to specifically target and knock-in or knock-out desired genes. 
By electroporating a DNA portion into a specific region of the embryonic brain, the 
embryonic brain cells will undergo neurogenesis, migration, and differentiation in order 
to develop into mature neurons that are found in various cortical tissue (Wang et al., 
2013). Electroporation means that an electric field will be applied on the selected cells 
A 
B 
that you wish to introduce foreign DNA to. By applying an electric field, it increases the 
cell membrane permeability, which allows foreign DNA to migrate across due to the fact 
that negatively charged DNA will be attracted to and migrate to the positive electrode. 
 As stated previously, an overexpression vector called pCAG will be included in 
the plasmid, which overexpresses for Green Fluorescent Protein (GFP). Expression 
vectors are used to take control gene expression of certain genes, thus controlling the 
proteins that are produced by said genes. In this case, the pCAG vector commandeers the 
GFP gene, controlling the production of GFP. By incorporating this overexpression 
vector in our methods, it will allow for the quantification of data once the embryonic 
brains are imaged. 
 The IUE protocol was followed for this particular procedure. Before performing 
the operation, the supplies were prepared. The glass pipette tips were pulled and loaded 
with plasmid. The pregnant mouse was anesthetized with isoflurane. Then, 
ketamine/xylazine and meloxicam were injected into the mouse and the abdomen was 
prepared for surgery. The fur was trimmed and disinfected, and an incision was made 
along the abdomen to expose the embryos. The embryos were gently pulled out and ready 
for DNA injection. The glass pipette tips were filled with the desired volume of DNA and 
were slowly injected into the ventricles of the embryos. The DNA was injected directing 
into the ventricles of the brain. Then, electrodes were clasped onto the embryos to deliver 
electrical pulses. This electroporation will allow the DNA to travel and migrate through 
the embryonic brain. These steps were repeated for all possible embryos, and enough 
time was allocated to place the embryos back and to suture the incision. The embryos 
were placed back into the cavity. The abdomen was sutured, and the mouse was placed 
back to recover fully from the anesthesia. The next day, the mouse was given an 
additional dose of meloxicam subcutaneously.  
Harvesting & Slicing 
 To allow for proper imaging and quantification of the embryonic brains, slicing of 
the brains and mounting them on slides will be performed. The brains slices will be 
coronal slices to allow for good imaging of the ventricles. The imaging channels that will 
be used are GFP (488 nm) and mCherry (568 nm). 
 The protocol for harvesting and slicing of embryonic brains was followed for this 
experiment. First, the embryonic brains were harvested from the embryos and fixed with 
paraformaldehyde overnight before being transferred to PBS. Slicing of the embryonic 
brains involved doing coronal slicing. The brains were sliced at 40 nm and placed in 
wells filled with PBS. The slices were then mounted on glass slides. Then, Prolong Gold 
was dotted along each of the glass slides so that the cover slip could be added on top of 
the mounted glass slide. The cover slips were sealed via nail polish after drying for a day. 
The glass slides were then used for microscopy and imaging. 
Microscopy & Imaging 
 A fluorescent microscope was used to image the brain slices. The slices were 
examined for overexpression of GFP and mCherry. Quantification was then performed 
regarding cell size and location to determine the effects of PGBD5 on embryonic brains. 
Three different quantification variables were examined, which were cell size, cell 
number, and distance from the surface of the cortex. The channels utilized were eGFP, 
mCherry, and DAPI. Pictures were taken using the three different imaging channels. 
Regular images and z-stack images were done to produce high-quality images. Then, a 
line tool was used on these collected images to quantify cell size and cell distance from 
the surface of the cortex. A cell counting tool was then used to count the number of cells 
in each image. 
Results: 
 After collecting the data and images, the results could finally be collect and 
quantified. The main quantifications that were used to compare the experimental brains 
versus the control brains involved cell number, cell size, and the cell distance from the 
cortex. A total of 7 brains from the experimental condition and 7 brains from the control 
condition were used in this analysis. A total of 25 experimental brain sections and 20 
control brain sections were analyzed. A total of on average 225 cells per brain section 
were analyzed. For quantification images were collected for both experimental and 
control brain slices. For experimental brains, DAPI stain channels and eGFP stain 
channels were utilized to examine the overall brain structure and the cells that took up the 
plasmids that contained GFP. For control brains, eGFP stain channels and mCherry stain 
channels were utilized to examine the cells that took up both eGFP and mCherry. An 
overlapping of these two channels indicated that there was co-localization in the control 





















Figure 8. Microscope images of experimental brain. Sections A-C show the images of 
an experimental brain with various imaging channels. Section A utilizes DAPI staining to 
show the brain region and structure. Section B utilizes eGFP staining to show the specific 
cells that took up the plasmid. Section C overlays the two staining channels and shows 







Figure 9. Microscope images of control brains. Sections A-D show the images of a 
control brain with various imaging channels Section A utilizes the eGFP channel to show 
the cells that took up the plasmid. Section B utilizes mCherry staining to show that the 
same localized group of cells also took up the other plasmid containing mCherry. Section 
C utilizes the DAPI channel to show the brain region and structure. Section D shows all 
three of the color channels and shows the co-localization of these plasmids, indicating 
that the same cells took up both GFP and mCherry. 
 
The images showed that the transfection worked for most of the brains. The plasmids 
were taken up and migrated across the embryonic mice brains, as indicated by the stains 
seen above. 
 Quantification was done after the images were taken. 25 experimental brain slices 
were examined and analyzed, and 20 control brain slices were examined and analyzed 
from 7 experimental brains and 7 control brains. Differences in cell counts, cell size, and 
cell distance from the surface of the cortex between the experimental and control brains 
were assessed. Cell counts were first examined. Cell counts for the experimental 
averaged out to be around 214 cells per brain slice. Cell counts for the control averaged 
out to be around 233 cells per brain slice. A t-test was done, and the p-value came out to 













Figure 10. Bar graph of averaged cell counts between experimental and control 
brains. The bar graph above shows the averaged cell counts between experimental and 
control brains. 25 experimental brain images were used and analyzed, and those 25 
individual points are scattered along the experimental X-axis. 20 control brain images 
were used and analyzed, and those 20 individual points were scattered along the control 
X-axis. The cell counts for experimental brains were, on average, lower than the cell 
counts for the control brains.  
 
 Cell size was then examined. The diameter of the experimental cells averaged out 
to be around 7.25 micrometers. The diameter of the control cells averaged out to be 6.55 
micrometers. A t-test was done, and the p-value came out to be 3.1e-9, which is below 
the .05 p-value threshold to be significant and suggest that PGBD5 increased the cellular 




























Figure 11. Bar graph of averaged cell diameter size between experimental and 
control brains. The bar graph above shows the averaged cell size between experimental 
and control brains in micrometers. 25 experimental brain images were used and analyzed, 
and those 25 individual points are scattered along the experimental X-axis. 20 control 
brain images were used and analyzed, and those 20 individual points were scattered along 
the control X-axis. The cell sizes for experimental brains were, on average, slightly larger 
than the cell sizes for the control brains. 
 
 Cell distance from the surface of the cortex was also examined and quantified. 
This was done by measuring the center of the cells to the top surface of the cortex. The 
distance found in the experimental brains averaged out to be around 437.96 micrometers. 
The distance found in the control brains averaged out to be around 536.98 micrometers. 
A t-test was done, and the p-value came out to be 4.8e-5, which is below the .05 p-value 























Figure 12. Bar graph of average cell distance from the surface of the cortex between 
experimental and control brains. The bar graph above shows the average cell distance 
from the surface of the cortex between experimental brains and control brains. 25 
experimental brain images were used and analyzed, and those 25 individual points are 
scattered along the experimental X-axis. 20 control brain images were used and analyzed, 
and those 20 individual points were scattered along the control X-axis. The cell distance 
for experimental brains averaged on to be slightly lower in value than the cell distance 
found in control brains. 
 
Discussion: 
 The results showed that the most significant effects of PGBD5 were on cell size 
and position. Cell growth primarily relies on signaling pathways that control and regulate 
the mTor pathway. This pathway includes PI3K, Akt, and mTOR and is regulated by Ras 
and PTEN. These regulators can be mutated in many tumors, leading to unregulated 
growth and proliferation (Dazert et al., 2011). I hypothesize that perhaps PGBD5 plays 
some role in affecting or influencing the signaling pathways to allow for more cell 
growth. As previously stated, PGBD5 has been found to promote oncogenic mutations, 
and these findings of experimental PGBD5 brains showing more cell counts supports 
those previous findings. In addition to possible mutations in signaling pathways, 
mutations in growth factor could possibly explain changes seen in cell size between 
experimental and control variables. Growth factors are molecules that can influence cell 
growth and cell proliferation (Goustin et al., 1986). Mutations involving growth factors 
potentially could affect cell size and cell counts, which could explain why experimental 
brain slices were observed to have slightly higher cell counts and cell size. 
 The cell distance from the surface of the cortex also showed significant 
differences between experimental and control brains. This means that cells that took up 
the experimental PGBD5 plasmid exhibited less migration towards the surface of the 
cortex. An explanation for this could be that the PGBD5 plasmid influences pathways 
and mechanisms that affect how far neuronal cells migrate in embryonic brain tissue. 
Such mechanisms involve cytoskeleton components that have the ability to sense its 
surroundings and react to various environmental signals (Kurosaka et al., 2008). Cell 
migration is a process that is heavily involved in cancer metastases as well, which could 
explain why PGBD5 was found to promote oncogenesis. 
 It is possible to see how a variety of influential factors could have caused such 
results found in this experiment. Factors such as signaling cascade pathways that affect 
growth and proliferation, growth factors, and cell migration all could have played some 
role as to why the experimental brains showed different values as to compared to the 
control brains. 
Conclusion: 
 In conclusion, the affects PGBD5 has on cell morphology still remains an 
ongoing mystery. However, the findings in this study in regards to cell counts, cell size, 
and cell distance help paint a clearer picture as to what PGBD5 potentially affects within 
the many pathways found in neuronal cells. Further investigation is recommended to 
examine what pathways PGBD5 plays a role in and how that could possibly affect cell 
morphology/physiology.  
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